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Abstract: The greatest advance in pediatric pain medicine is the recognition that untreated 
pain is a significant cause of morbidity and even mortality after surgical trauma. Accurate 
assessment of pain in different age groups and the effective treatment of postoperative pain is 
constantly being refined; with newer drugs being used alone or in combination with other drugs 
continues to be explored. Several advances in developmental neurobiology and pharmacology, 
knowledge of new analgesics and newer applications of old analgesics in the last two decades 
have helped the pediatric anesthesiologist in managing pain in children more efficiently. The 
latter include administering opioids via the skin and nasal mucosa and their addition into the 
neuraxial local anesthetics. Systemic opioids, nonsteroidal anti-inflammatory agents and regional 
analgesics alone or combined with additives are currently used to provide effective postopera-
tive analgesia. These modalities are best utilized when combined as a multimodal approach to 
treat acute pain in the perioperative setting. The development of receptor specific drugs that can 
produce pain relief without the untoward side effects of respiratory depression will hasten the 
recovery and discharge of children after surgery. This review focuses on the overview of acute 
pain management in children, with an emphasis on pharmacological and regional anesthesia 
in achieving this goal.
Keywords: pediatric pain treatment, pain medication in children, pediatric regional anesthesia, 
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Introduction
The practice of pediatric pain management has made great progress in the last decade 
with the development and validation of pain assessment tools specific to pediatric 
patients. Prior to that, adequate assessment and treatment of pediatric pain lagged 
behind that of adult analgesia due to a lack of clinical knowledge, insufficient pediatric 
research, and the fear of opioid side effects and addiction. The guidelines provided by 
organizations such as the American Pain Society (APS) and the Agency for Health Care 
Research and Quality (ARQ), as well as mandates issued by the Joint Commission on 
Accreditation of Healthcare Organizations (JCAHO) led to the inclusion of pediatric 
analgesic trials to provide evidence-based pain management guidelines in children of 
all ages. Almost all the major children’s hospitals now have dedicated pain services 
to provide evaluation and immediate treatment of pain in any child. A multimodal 
approach to preventing and treating pain is usually used. Mild analgesics, local and 
regional analgesia, together with opioids when indicated, are frequently combined to 
minimize side effects of individual drugs or techniques.Journal of Pain Research 2010:3 submit your manuscript | www.dovepress.com
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Pain assessment
The ability to assess pain in children appropriately by using 
standardized pain scores has improved the clinician’s abil-
ity to treat postoperative pain in children over the past few 
years. Children suffer postoperative pain in the same way 
as adults. The main difference is that factors such as fear, 
anxiety, coping style and lack of social support can further 
exaggerate the physical pain in children. The analgesic 
requirement following surgery does not depend on the age 
of the patient but on the nature of the procedure and the 
pain threshold of the patient. Pain assessment is a criti-
cal   component of pain management in any patient. A full 
description of the   different ways to assess pain in children is 
available in text books which detail pediatric pain treatment 
in both the acute and chronic setting.1 However, assessing 
pain in young children can be challenging if they are non-
verbal or have   developmental disabilities. The perception 
and communication of the child’s pain depends on his or 
her intellectual and social development. Expression of pain 
therefore relies on the child’s ability to understand, quanti-
tate and communicate it. Self-reporting which is the “gold 
standard” for assessment is possible only in older children 
or those with cognitive and communicative abilities. Adult 
scales have been modified and converted to a simple format 
to enable the child to understand and quantify pain. Self-
reporting scales require that a child has the cognitive ability 
to pinpoint the degree of pain on a relative scale. In the last 
decade, a variety of tools to assess pain and age appropriate 
pain assessment scales have become clinically available 
to provide qualitative and quantitative information as well 
as the documentation of pain. At the Children’s National 
Medical Center, Washington, DC different pain scales are 
used to assess pain in children. Our post anesthesia care unit 
(PACU) record requires the   assessment and documentation 
of pain scores for each patient on arrival; every time that 
vital signs are recorded and prior to discharge to the floor.2 
(Figures 1 and 2) The measurements of pain in newborns, 
infants, young children, and children with developmental 
disabilities who are unable to self-report have also undergone 
major improvements. There are numerous clinical practice 
guidelines and policy statements that have been published 
on pediatric pain.3
Behavioral measures of pain include behavior checklists 
that provide a list of pain behaviors that are looked for, and 
if present, a numerical score is given. The total number of 
behaviors that are present in the child are then used to esti-
mate his/her pain at the time of assessment. Irrespective of 
the tool selected, assessment of postoperative pain is greatly 
facilitated by introducing the concept of pain rating and of 
the tool itself during the preoperative preparation of the child. 
These pain assessment tools may facilitate reliable and valid 
observational pain assessment in children with cognitive 
impairment who cannot self-report their pain. Objective pain 
assessment is important to facilitate effective postoperative 
pain management in these vulnerable children.4
Perioperative pain management therefore begins during 
the preoperative visit by preparing both the parent and the 
child about the upcoming surgery and information about 
the type of pain that is associated with it. The knowledge 
regarding the different types of drugs, blocks, and their effec-
tiveness, as well as the side effects must be conveyed to the 
parent prior to surgery. The type of analgesia that will be a 
part of the anesthetic plan should be shared with the fam-
ily particularly if the plan is to use a single-dose regional 
technique, continuous epidural catheter technique, or patient 
controlled analgesia (PCA). The current trend is to provide 
preemptive regional blocks before surgery, after anesthetic 
induction, as well as postoperative local infiltration of the 
wound, in an attempt to lessen the need for narcotics dur-
ing recovery. An ideal way to provide better postoperative 
analgesia in children is the use of multiple analgesics with 
additive or synergistic effects, yet with different side effect 
profiles so that adequate analgesia can be provided with 
the least amount of side effects. Moderate to severe pain in 
any patient is best treated with a combination of analgesic 
techniques. Pain can be treated at the peripheral level using 
local anesthetics, peripheral nerve blockade, nonsteroidal 
anti-inflammatory drugs (NSAIDs), or opioids. At the brain 
level it can be treated with local anesthetics, opioids, and 
α2 agonists.
Pharmacological interventions
Nonopioid analgesics
Acetaminophen (Paracetamol), Ibuprofen, Naproxen, 
Diclofenac, and Ketorolac are the nonopioid analgesics that 
are available for the treatment of pain. When used alone, 
they are adequate to treat mild pain although they need to be 
combined with other agents for treating moderate to severe 
pain. These drugs have a ceiling effect and are best used in 
combination with opioids to decrease the dose of the opioids 
and thus their side effects.
Acetaminophen
Acetaminophen is an antipyretic with weak analgesic prop-
erties. It exerts the antipyretic effect at the hypothalamus 
and the analgesic effects by blocking central prostaglandin Journal of Pain Research 2010:3 submit your manuscript | www.dovepress.com
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synthesis, reducing substance P-induced hyperalgesia, and 
modulating the production of hyperalgesic nitric oxide in the 
spinal cord.1 Pharmacokinetic studies have changed the tra-
ditional dosing guidelines for acetaminophen in children.5 
The initial dose is up to 45 mg/kg administered rectally 
before awakening from anesthesia.6 Additional doses can be 
given orally (10–15 mg/kg) or rectally (20 mg/kg) round the 
clock (RTC) every 4–6 hours (and not as needed) to produce 
analgesia with the maintenance of an adequate blood level 
of 10–20 mcg/mL.7 The total daily dose of acetaminophen, 
via any route, should not exceed: 100 mg/kg for children; 
75 mg/kg for infants; 60 mg/kg for term and preterm neonates 
Figure 1 Pain Scales.
Notes: At Children’s National Medical Center (CNMC), Staff have a choice among three different scales to assess a child’s pain. The Objective Pain Scale (OPS) is used 
for children up to 3-years of age or nonverbal children. The wong-Baker Faces Rating Scale is used for persons age 3 and over, and the Lineal Analog Pain Scale is used for 
older children and adolescents.Journal of Pain Research 2010:3 submit your manuscript | www.dovepress.com
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older than 32 weeks post conceptual age; and 40 mg/kg for 
preterm neonates younger than 32 weeks post conceptual 
age.8 Studies in children undergoing tonsillectomy and cleft 
palate repair however did not show an analgesic value of the 
recommended doses of acetaminophen.9,10
Acetaminophen may be combined with codeine for 
more effective control of moderately severe pain and/or 
discomfort. Acetaminophen with codeine elixir contains 
120 mg acetaminophen and 12 mg codeine per 5 mL. The 
usual dose is 5 mL for children 3–6 years, and 10 mL for 
the 7–12 age group.11 This combination is also available as 
tablets Tylenol 1, 2, 3, and 4 – the number referring to the 
quantity of codeine in each tablet (T1 has 7.5 mg codeine, 
T2 has 15 mg codeine, T3 has 30 mg codeine and T4 has 
Figure 2 PACU record at CNMC.
Notes: Pain is assessed and a Pain Score documented when the child arrives in PACU (A), upon discharge (B), and every time vital signs are recorded (C). Similar assessments 
and documentation are made on the Pediatric Flow Sheet for in-patients at minimum every 8-hour shift.
Abbreviations: CNMC, Children’s National Medical Center; PACU, post anesthesia care unit.Journal of Pain Research 2010:3 submit your manuscript | www.dovepress.com
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60 mg codeine). Hepatotoxicity has been reported with doses 
of acetaminophen only slightly above the recommended 
10- to 15 mg/kg/dose orally for a total of five doses or 50 to 
75 mg/kg/day, suggesting that acetaminophen may have a 
narrow therapeutic index.12
A study comparing rectal and intravenous   administration of 
therapy with acetaminophen showed that rectal   acetaminophen 
40 mg/kg provided longer analgesia for   moderately painful 
procedures when compared with 15 mg/kg   acetaminophen 
administered intravenously.13
Acetaminophen is available in a wide variety of oral 
formulations alone or in combination with decongestants 
in cold remedies and with opioids for the treatment of 
  moderate to severe pain. The wide range of over the-counter 
acetaminophen-containing products poses a potential risk 
of overdosing children who may be given more than one 
  formulation that contains the drug. Parental education as well 
as frequent review of the patient’s medications is needed to 
minimize the risk of overdose.
Nonsteroidal anti-inflammatory drugs (NSAIDs)
NSAIDs inhibit the enzyme cyclooxygenase (COX), reduce 
the production of prostaglandins at the site of tissue injury, 
and diminish the inflammatory cascade.
The COX-1 enzyme is present in the brain,   gastrointestinal 
tract, kidneys, and platelets and preserves gastric mucosal 
integrity and function, platelet aggregation, and renal 
  perfusion. Blocking the COX-1 enzyme therefore can 
result in injury to gastric mucosa, platelet dysfunction and 
decrease renal perfusion. COX-2 expression is induced by 
  inflammation or tissue injury.
Selective COX-2 inhibitors reduce inflammation 
although they have less effect on gastric mucosal function 
and have fewer effects on platelet aggregation, thereby 
resulting in fewer side effects. The development of selective 
  Cyclooxygenase (COX-2) inhibitors that can alleviate pain 
and inflammation without inhibiting the platelet function 
(mediated by the COX-1-derived prostanoids) appears to 
be an ideal way to treat pain in pediatric patients. A study 
evaluating the analgesic effectiveness of acetaminophen 
combined with either ibuprofen or rofecoxib showed that 
the addition of ibuprofen although not rofecoxib, reduced 
the need for early analgesia following tonsillectomy by 50% 
when compared to acetaminophen alone.14 Another study 
that evaluated 66 children, aged 3–11 years-of-age, scheduled 
to undergo tonsillectomy, found that a single preoperative 
dose of rofecoxib (1 mg/kg) resulted in less vomiting and 
lower 24-hour pain scores in pediatric patients undergoing 
an   elective tonsillectomy.15 In addition to their peripheral 
effects, the NSAIDs have also been shown to exert a direct 
spinal action by blocking the hyperalgesic response induced 
by activation of spinal glutamate and   substance P receptors.16 
Diclofenac provides effective analgesia after minor surgical 
procedures in children. The pediatric dose of diclofenac is 
1 mg/kg every 8 hours orally, rectally, or intravenously. It is 
available only as an oral tablet in the United States, although 
it is available as a suppository and in the injectable form in 
several countries. When diclofenac was administered rectally, 
the relative bioavailability was greater and the peak concentra-
tion was reached earlier than after oral administration.17
Among the nonselective NSAIDs, Ketorolac Tromethamine 
is still the only intravenous (IV) form of NSAID available in 
the United States. Optimal postoperative analgesia is possible 
if the drug is given early, immediately following induction, 
since the onset of pain relief is 20 to 30 minutes following its 
administration. The analgesic and opioid-sparing effects of 
ketorolac, which may reduce the incidence of opioid-related 
adverse effects such as respiratory depression, nausea and 
vomiting, have been demonstrated by numerous studies in 
children.18 A recent study in young children treated with 
ketorolac alone after minimally invasive open ureteroneocys-
tostomy with a small incision showed that it was associated 
with a short length of stay and low pain scores.19 Intravenous 
ketorolac (0.5 mg/kg) has also been shown to reduce the 
frequency and severity of postoperative bladder spasms after 
ureteral reimplant procedures in   children.20 These spasms can 
be extremely uncomfortable, can occur in spite of a regional 
analgesic blockade, and are poorly treated with most opioid 
analgesics. Ketorolac appears to suppress bladder contrac-
tions and increase bladder   capacity by lowering bladder 
prostaglandin levels, thereby reducing the C-fiber mediated 
bladder pain and hyperactivity.
The untoward side effects of Ketorolac include decreased 
bone repair after osteotomy, bronchospasm, acute renal 
failure and possibly increased surgical bleeding secondary 
to altered platelet function.21 Earlier studies have reported 
an increased incidence of bleeding in patients who received 
ketorolac   following tonsillectomy.22,23 A   quantitative   systemic 
review of 25 studies examined the risk of   bleeding after 
  tonsillectomy when NSAIDs were used in 970 patients. Of the 
four   bleeding end points, namely, blood loss,   postoperative 
bleeding, hospital admission, and re-operating because of 
bleeding, only re-operation happened   significantly more 
frequently with NSAIDs. Compared to opioids, NSAIDs 
were   equianalgesic, with less risk of postoperative nausea 
and vomiting (PONV).23Journal of Pain Research 2010:3 submit your manuscript | www.dovepress.com
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Dextromethorphan
Dextromethorphan is a weak N-methyl-d-aspartate (NMDA) 
receptor antagonist that inhibits spinal cord sensitization 
in animal models of pain as well as the development of 
cutaneous secondary hyperalgesia after tissue trauma. 
  Dextromethorphan is an antitussive ingredient, and an isomer 
of the codeine analog levorphanol with an analgesic effect 
via the noncompetitive NMDA receptor antagonism. The 
efficacy of the preoperative use of dextromethorphan for 
control of post-adenotonsillectomy pain is controversial. 
Dawson and colleagues reported a 34% reduction in the 
need for intravenous (IV) morphine during the first 6 hours 
after surgery in children who received a single 1 mg/kg 
dose of dextromethorphan preoperatively.24 However; there 
was no difference in oral analgesic consumption or type 
of diet tolerated from controls beyond 6 hours. Rose and 
  colleagues however could not duplicate the reported efficacy 
of   dextromethorphan in reducing post-adenotonsillectomy 
pain in patients who received preoperative morphine and 
acetaminophen analgesia.25 Another study where oral 
  dextromethorphan cough syrup (1 mg/kg) given preopera-
tively was compared to intravenous tramadol (1 mg/kg) given 
after induction of anesthesia. The latter was found to be more 
effective in reducing post-tonsillectomy pain in children.26 
The lack of activity at the mu-receptors, and thus the lack of 
undesirable opioid side effects such as respiratory depression, 
and PONV is the most desirable feature of this drug.
Tramadol
Tramadol is a synthetic analog of codeine, although it is 
not a controlled drug. It is an analgesic agent with medium 
potency. It is a unique drug with two complementary mecha-
nisms of action. One of its metabolites has a weak affinity for 
the mu-opioid receptors without any affinity for the two delta 
or kappa receptors. The second mechanism is its ability to 
inhibit the reuptake of the neurotransmitters norepinephrine 
and serotonin. Tramadol causes less sedation compared to 
other opioids with minimal effects on respiration which is an 
advantage over the opioid analgesics used for postoperative 
pain relief in children. A study with oral tramadol in children 
demonstrated a dose-ranging effect, with patients receiving 
a 2 mg/kg dose requiring 42% less rescue analgesics than 
those who received a 1 mg/kg dose.27 An intravenous dose 
of tramadol 1–2 mg/kg has been shown to be a suitable 
  alternative to intravenous morphine in post-tonsillectomy 
patients.28 The most troubling side effect of tramadol is the 
increased incidence of PONV, (9%–10%) pruritus (7%) 
and rash (4%). This is more likely with postoperative oral 
administration than with intraoperative IV use. Tramadol 
also has a distinct advantage over NSAIDS because of its 
lack of inhibition on prostaglandin synthesis. Oral   tramadol 
has been shown to have the same analgesic efficacy as oral 
diclofenac for   post-tonsillectomy pain in patients 11 years 
and older, without the side effects of NSAIDs.29 It is 
  important to note that the use of ondansetron to treat PONV 
results in the   inhibition of tramadol analgesia probably due 
to a   reduction of binding to the 5-HT3 receptors at the spinal 
level.30 Tramadol is currently available in a tablet form alone 
or in combination with acetaminophen in the USA. Its avail-
ability in other countries as an injectable form, liquid form 
and suppository form provides more flexibility in using this 
drug in the perioperative period. It is best used as an analgesic 
supplement to treat mild to moderate pain because of it opioid 
sparing effect and low incidence of side effects.
Opioid analgesics
The word “opium” is derived from the Greek word meaning 
juice and refers to the juice of the poppy plant. Opioids exert 
their effects similarly to the endogenous opioid peptides 
  met-enkephalin, beta-endorphin, and dynorphin which act at 
specific opioid receptors. These opioid receptors are found 
in the presynaptic and postsynaptic sites in the brain, spinal 
cord, and peripheral nerve cells. The activation of these 
different receptors in the central nervous system (CNS) 
namely, mu, kappa, delta, and sigma causes neuronal inhibi-
tion by   decreasing the release of excitatory neurotransmitters 
from the presynaptic terminals. The drugs that act by exerting 
their effects on opioid receptors are classified as agonists, 
antagonists, partial agonists and mixed agonist-antagonists.
A clear knowledge of the type of opioid receptor that is 
being activated and the effect of stimulating or blocking each 
is important to the clinician before prescribing these drugs 
and the drugs to reverse their action should the need arise. 
Mu receptors are present as two types: mu1, when activated 
produce supraspinal analgesia and physical dependence; 
mu 2 receptors are responsible for respiratory depression, 
  bradycardia, physical dependence, and   gastrointestinal 
dysmotility. Morphine, codeine, hydromorphone,   fentanyl, 
sufentanil, alfentanil, meperidine and methadone are 
some of the agonist drugs that are commonly used by the 
  anesthesiologists in acute pain management.
The activation of the other receptor kappa causes   analgesia 
without significant respiratory depression and the drugs that 
act on these receptors are dynorphin,   pentazocine,   butarphanol, 
nalbuphine, buprenorphine, and nalorphine. The activation 
of the sigma receptors produces dysphoria,   hypertonia, Journal of Pain Research 2010:3 submit your manuscript | www.dovepress.com
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  tachycardia, tachypnea and mydriasis.   Pentazocine and 
  ketamine are 2 agonist drugs that act on the sigma receptors. 
The effect of the drugs at the mu, delta, and kappa receptors 
can all be reversed by naloxone, an antagonist that simply 
binds to these receptors and block the effect of the agonist. 
There are partial agonists that act with reduced intrinsic activ-
ity thus producing less than a maximal response and mixed 
agonist and antagonists that act as agonists at certain opioid 
receptors and as antagonists at the other.1
A short acting drug is usually chosen when opioids are 
indicated in the immediate recovery period. Intravenous 
use allows more accurate titration of the dose and avoids the 
use of “standard” dosages based on weight, which may lead 
to under-medication or relative overdose. Fentanyl, up to a 
dose of 2 µg/kg, is the drug of choice for intravenous use. In 
the absence of an intravenous route, meperidine (0.5 mg/kg) 
and codeine (1.0–1.5 mg/kg) can be used intramuscularly. 
Intramuscular (IM) codeine tends to result in less vomiting 
than other opioids, especially morphine.31 However, children 
are so fearful of IM injections that they often will deny pain 
to avoid the therapeutic and equally painful injection. Other 
novel routes of administration like the nasal administration 
of fentanyl has been shown to result in an analgesic blood 
level comparable to that following IV use, making it useful in 
children who do not have, or have lost, their IV access.32,33
It is very important to exercise caution when opioids are 
used in neonates and young infants. They have increased 
susceptibility to apnea because of the relative imbalance of 
mu 1 (analgesia) to mu 2 (respiratory depression) receptors. 
They also have increased susceptibility to hypoventilation 
because of a decreased ventilatory response to hypoxia 
and hypercapnea. Due to their immature liver conjugation 
(glucuronidation, sulfation, and oxidation) and immature 
renal filtration, the metabolism and excretion of opioids and 
their metabolites are markedly decreased. In addition, there is 
a higher concentration of the drug in the brain because of an 
immature blood-brain barrier. Newborns and young infants 
less than 4–6 months of age also have increased free fraction 
of the drug in the blood because of decreased plasma protein 
(less alpha-1 acid glycoprotein and albumin) binding.
Codeine, Oxycodone (Tyelox, Percocet) and hydrocodone 
(Vicodin, Loratab) are opioids used when parenteral opioids 
need to be converted to enteral ones. These have a 60% 
  bioavailability after oral ingestion. The analgesic effects 
occur 20 minutes after ingestion and reach a maximum by 
60–120 minutes. Only 10% of the codeine is metabolized into 
morphine and this portion is responsible for the analgesic effect 
of codeine. Usual dose is 0.5mg to 1mg/kg of codeine.
When opioids are administered as boluses, there are 
always break through periods of pain between the peaks 
and troughs of analgesic levels. An optimal way to avoid the 
most serious complication of opioid therapy, the   respiratory 
depression and apnea is to titrate the drug slowly in divided 
doses and to monitor the respiratory rate carefully by   clinical 
observation as well as by setting the alarm limits on the 
respiratory rate in the patient’s monitor. The ability to treat 
apnea by assisting or controlling ventilation by bag and mask 
ventilation and availability of intravenous naloxone to reverse 
the ventilatory depression must accompany any opioid 
therapy. It is also important to have a functioning suction at 
hand because of the high possibility of nausea and vomiting 
following the administration of single boluses of narcan. 
Other unwanted effects of giving narcan   administration 
are tachycardia, hypertension and occasionally pulmonary 
edema. Younger children develop a tolerance to opioids 
and benzodiazepines more rapidly than older children. The 
management of tolerance and withdrawal has now become 
a nearly universal consequence of prolonged administration 
of these medications to critically ill neonates, infants, and 
children.
Intravenous patient controlled 
analgesia in children
Intravenous patient-controlled analgesia (IV-PCA) is one of 
the most effective methods to achieve optimal postoperative 
analgesia in adults and children. IV-PCA provides effective 
pain treatment, adjusts the dose according to individual 
needs, and allows the patients to be in control of their 
pain   management decisions. The use of this technique has 
expanded to even young children. Not only does IV-PCA 
provide consistent opioid blood levels, it also spares children 
the pain of IM injections that used to be routinely used for 
postoperative opioid administration.
An appropriate IV opioid loading dose to initiate adequate 
analgesia is necessary when planning an IV-PCA-based anal-
gesic regimen. Morphine is the most commonly used   opioid 
for pediatric IV-PCA and the dose is based on the child’s 
body weight. The optimum bolus dose (usually 0.02 mg/kg) 
is the minimum dose required to produce   satisfactory 
analgesia without causing significant side effects. Lockout 
periods should provide sufficient time for the improved 
analgesia to be noted. Although there is no “  correct” or 
“optimal” lockout period, a range of 5–10   minutes is usu-
ally prescribed.
The overall quality of analgesia and the ability to have 
better sleep quality with less bolus requirements at night Journal of Pain Research 2010:3 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
112
Verghese and Hannallah
can be improved by the addition of background infusion to 
on-demand IV-PCA. Those who object to the addition of 
this background infusion raise the concern that the use of 
background infusion may increase the total dose of opioid 
used, and therefore increase the incidence of opioid-related 
side effects such as excessive sedation, nausea and respira-
tory depression without apparent improved pain scores.34 
However, Yildiz and colleagues reported that by decreasing 
the bolus dose by 50%, the total opioid (meperidine) con-
sumption was actually lower when a background infusion was 
added as compared to bolus dosing alone, with no statistical 
differences in pain, sedation, and nausea scores between the 
two regimens.35
IV-PCA should be available to any child who understands 
the concept of pushing a button to take away the pain. The 
maturity of the child, the familiarity with the equipment and 
hospital environment, the support of the parents, are factors 
that can encourage early use. Education of the patient and 
the family about the PCA device is very important before 
instituting PCA in any pediatric patient. Because of its 
reasonably long duration of action and mild sedative effect, 
morphine is the most commonly used opioid for PCA in 
children. Similar to all other opioids, morphine can also 
cause nausea, vomiting, pruritus, decrease GI function, and 
possibly urinary retention. When morphine is contraindicated, 
or if dose-limiting adverse effects are encountered, fentanyl 
or hydromorphone can be used. Fentanyl has faster onset 
and shorter duration than morphine. A background infusion 
is usually required when dealing with a child with constant 
pain. In children and adolescents, a small-dose naloxone infu-
sion (0.25 µg/kg/hour) can significantly reduce the incidence 
and severity of opioid-induced side effects without affecting 
opioid-induced analgesia. When initiating morphine IV-PCA 
for the treatment of moderate to severe pain, clinicians should 
strongly consider starting a concomitant small-dose naloxone 
infusion.36 However, when dealing with children who may 
be experiencing intermittent, severe pain of short duration, 
fentanyl boluses may be particularly effective owing to the 
rapid onset and short duration of action.
Hydromorphone, with a potency 7 times that of morphine 
is a hydrogenated ketone of morphine and frequently used 
as an alternative to morphine in children who are intoler-
ant to morphine.37 Although hydromorphone has not been 
demonstrated to be superior to morphine in terms of anal-
gesic efficacy or side-effect profile, it is frequently chosen 
in patients with renal problems because it has no active 
metabolites. The half-life elimination of hydromorphone is 
3–4 hours and is typically associated with fewer side effects 
than morphine (nausea, vomiting, pruritus) and useful in 
sickle cell patients during the treatment of their pain crises. 
The addition of NSAID drugs such as ketorolac to morphine 
IV-PCA regimen has been shown to decrease the morphine 
requirements and the opioid-related side effects.38
Intravenous nurse or parent 
controlled analgesia in children
A rather controversial variation on the use of PCA technol-
ogy in children is that of nurse or parent-assisted PCA also 
known as NCA and Pr CA.39 The technique is controversial 
because of concerns regarding the risk of overdosage and the 
potential for respiratory depression if someone other than the 
patient is allowed to administer bolus doses. Advocates of this 
approach maintain that it allows young children, and those 
who are physically or cognitively impaired to receive the 
same PCA benefits as older children.39 Children are started on 
small-dose continuous opioid infusion. The protocol allows 
the bolus doses of opioid to be administered by a nurse or 
parent to treat acute exacerbations of pain. In a series of 
240 treatments in 212 patients there was a 1.7% incidence of 
apnea and episodes of desaturation requiring treatment with 
naloxone.40 These findings reinforce the need for treatment 
paradigms and close patient monitoring to minimize the risk 
and allow for effective intervention when someone other than 
the patient activates IV-PCA devices.
Nurse-controlled analgesia (NCA) is an alternative suit-
able and convenient delivery system of controlled drugs by 
nursing staff that allows them to work around the policies 
regarding handling of narcotics that can cause delay in pain 
relief. Using the “PCA” pump, the nurse can immediately 
administer a pre-calculated and programmed analgesic 
dose once the assessment of pain is made without leaving 
the patient’s bedside. The use of IV-PCA devices allows 
timely administration of opioids by the nurse and when appro-
priately used, it is an excellent patient care convenience and 
safety initiative. Currently NCA, though not parent assisted 
analgesia, is a well-established practice and considered to be 
a generally safe and effective method for delivering opioids 
to children who are unable to self-administer. Based on docu-
mented decreasing bolus demands and ability to tolerate oral 
fluids, children can be weaned from PCA. If a background 
infusion is used, it is usually stopped first. The total daily 
opioid doses prior to weaning can be used to calculate the 
appropriate equivalent of oral analgesics. There are several 
causes that can make PCA unsafe. These include improper 
patient selection, inadequate patient education, unauthorized 
activation of the PCA device, inadequate staff training and Journal of Pain Research 2010:3 submit your manuscript | www.dovepress.com
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errors due to inappropriate prescription, drug dispensing, and 
PCA pump programming.
Regional anesthesia in children
In pediatric patients the regional blockade is often used for 
analgesia in combination with general anesthesia. If the 
block is placed before the surgical incision (after the anes-
thetic induction) it can decrease the amount of the narcotics 
and inhalational agents needed intraoperatively and the side 
effects of the opioids (nausea, vomiting, hypoventilation, 
and drowsiness) postoperatively. The regional block can 
be single shot caudal analgesia or a continuous caudal or 
epidural block for postoperative analgesia.
There are some important pharmacologic principles of 
local anesthetics in children that must be kept in mind before 
administering local anesthetics to young children.41 These 
include the following: (1) there is a potential for toxicity in 
infants and young children when continuous infusions of 
local anesthetics are employed because of their prolonged 
elimination half-lives; (2) local anesthetics lower the seizure 
threshold; (3) decreased albumin and alpha1-acid glycopro-
tein serum levels in the young infant can result in less binding 
of the local anesthetic and thus higher concentrations of the 
free drug, once again increasing the potential for toxicity.
Maximum recommended doses of local anesthetics for a 
particular block should be well known prior to administering 
the drug, whether it is used alone or in combination with 
epinephrine. Lidocaine 5 mg/kg may be used alone or up to 
7 mg/kg if lidocaine is used with epinephrine. Bupivacaine 
has a maximum recommended dose of 2.5 mg/kg when used 
alone compared to 3 mg/kg when combined with epinephrine. 
It is also very important to avoid the addition of epinephrine 
to local anesthetics if they are injected into an area of end 
artery distribution (penis, digit).
Spinal block
Spinal anesthesia can be used as a sole anesthetic in former 
preterm infants at risk for postoperative apnea undergoing 
inguinal hernia repair. It is important to note that the dural 
sac in the neonate ends at S3 and migrates cephalad to S1 
during the first year of life. The procedure is usually done in 
the sitting position, with neck, chin and the head extended 
and supported by an assistant to maintain an unobstructed 
airway.
epidural/caudal blocks
The epidural space in a child can easily be reached with 
a caudal approach without the risk of dural puncture, as 
compared to an approach via the thoracic or lumbar route. 
Single-shot caudal analgesia is the most useful and popular 
pediatric regional block.42 Pediatric anesthesiologists with 
extensive clinical experience attest to the ease of perfor-
mance, reliability, and safety of the caudal block especially 
in patients weighing over 10 kg.43 Although caudal block 
appears simple to perform, one must have respect for the 
rare and potentially serious complications that can occur 
with any regional technique. Single-shot caudal blocks are 
ideally suited for surgical procedures below the level of 
the umbilicus.44 Analgesia for higher dermatomes can be 
achieved at the expense of a larger volume of local anesthetic 
or by threading a catheter into the caudal space. This latter 
method of introducing a catheter through the caudal space in a 
sterile fashion can allow for continuous infusion or repeated 
administration of medications, prolonging the analgesia for 
as long as necessary.
Single-shot caudal analgesia
The anatomy of the caudal space must be well understood 
before attempting such a block. The block is placed with 
the anesthetized patient in the lateral decubitus position 
after the sacral area is sterilely prepped and the landmarks 
identified by palpation. The needle is advanced through the 
sacral hiatus in the midline between the cornua at a 45-degree 
angle and after the needle pops through the sacrococcygeal 
ligament, the needle-to-skin angle is reduced so that the 
needle is advanced 2–3 mm into the caudal space parallel 
to the spinal axis.
The three important variables that determine the quality, 
duration, and extent of a caudal block are volume, total dose, 
and concentration of the local anesthetic. It is still not very 
clear whether age or weight is the best criterion for   selecting 
a dose to achieve the desired level of caudal analgesia in 
children. A study evaluating the correlation of spread of the 
local anesthetic to age and weight was undertaken by Busoni 
and Andreuccetti. They noted that both age and weight were 
predictors of the desired level of analgesia, although weight 
was a better predictor in newborns and infants and age was 
a better guide in older children.45
Even today the most workable formula for clinical use is 
the one suggested by Armitage which correlates the level of 
block with the volume of local anesthetic injected.46 In order 
to achieve a sacral or a T-10 level, the volume is 0.5 mL/kg 
is used, while for a lower to mid-thoracic levels, the volume 
is 1 and 1.25 mL/kg respectively. If there is no opportunity 
to repeat a single-shot block, the initial dose must be large 
enough to produce the required level of analgesia. Children Journal of Pain Research 2010:3 submit your manuscript | www.dovepress.com
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can become distressed if they cannot feel their legs or move 
them. Therefore it is important to avoid using concentrations 
of local anesthetic agents strong enough to cause motor 
blockade. The maximum dose of bupivacaine recommended 
is 2.5 mg/kg, which roughly translates to 1 ml/kg of body 
weight of the patient when the usual concentration of 0.25% 
is used. Therefore it is important to lower the concentration 
of the bupivacaine from 0.25% to 0.2% or even 0.18% if 
the volume is to be increased as suggested by Armitage 
(1.25 mL/kg for mid-thoracic level).
Confirming the effectiveness of the caudal block by testing 
the level of sensory blockade requires an awake, co-operative, 
older patient. The anesthesiologist’s ability to decrease the 
concentration of inhaled anesthetic without using opioids dur-
ing surgery is often considered to indicate a successful caudal 
block. On the other hand when undergoing hypospadius or 
orchidopexy or hernia operation under mask administered 
general anesthesia supplemented with a caudal block, penile 
erection and tightening of lower abdominal muscles, hyper-
ventilation, vocalization and sympathetic stimulation are 
physiologic parameters that are evident if the caudal block 
is inadequate. Another simple test is to confirm the effective-
ness of the caudal block in children, is to evaluate the laxity 
of the patient’s anal sphincter by placing an acetaminophen 
suppository after the block has set in.47 The presence of a lax 
anal sphincter at the end of surgery correlates significantly 
with the reduced administration of opioids intraoperatively 
and in the PACU. The presence of a tight sphincter at the 
end of surgery may suggest an inadequate block, the need 
to repeat the block before the child awakens, or to consider 
alternate methods of postoperative analgesia.
The pharmacokinetics of bupivacaine after caudal anes-
thesia in infants receiving 2.5 mg/kg of bupivacaine have 
been studied by Mazoit and colleagues when the serum levels 
were found to be in the range of 0.5–1.9 µg/mL, with peak 
plasma levels occurring 10–60 minutes after administration.48 
Eyres and others measured plasma bupivacaine concentra-
tions after caudal injection of 3 mg/kg of 0.25% bupivacaine 
in 45 children whose ages ranged from 4 months to 12 years 
and found mean blood levels ranging from 1.2–1.4 µg/mL, 
which are well below the limits projected to be toxic in 
adults.49 The peak plasma levels of bupivacaine were less than 
those considered toxic in adults in all pediatric studies.
Another interesting method to quantitate the duration of 
caudal analgesia in children was demonstrated by Bromage 
is by recording the time that elapses before the block level 
had receded by at least two spinal segments. The duration 
was found to be 2 hours when bupivacaine was used alone, 
although slightly longer if an epinephrine-containing local 
anesthetic solution was used. He also noted that the total dura-
tion of action in the lower sacral segments was considerably 
longer than the time that elapsed before recession began. This 
observation correlates well with clinical experience, where 
bupivacaine caudal analgesia, as judged by the time elapsing 
before the child requires supplemental analgesia, may persist 
for 4 or 5 hours.50
The single-shot caudal block has a significant   disadvantage 
because of its limited duration of action (90–120   minutes 
with bupivacaine).51 Numerous attempts to prolong the 
analgesic effects of a single-shot caudal block by combin-
ing a local anesthetic drug with other additives has been 
studied by many investigators. Narcotics, the alpha-2 
  agonists (  clonidine,   dexmedetomidine), epinephrine, sodium 
  bicarbonate,   tramadol, neostigmine, s-ketamine are some of 
the additives that have been studied and used to prolong and 
improve the efficacy of the caudal block in children. Addi-
tion of   preservative free morphine to local anesthetics has 
been noted to prolong the duration of analgesia after major 
surgical procedures.51 Jamali and others reported on the use 
of clonidine as an adjunct for pediatric caudal analgesia. 
They compared bupivacaine alone (0.25%, 1 mL/kg); with 
bupivacaine and epinephrine (1:200,000); and with bupiva-
caine and clonidine (1 µg/kg) for postoperative analgesia.52 
Adding clonidine to the caudal analgesic mixture was 
found to more than double the analgesic time. There were 
no differences in respiratory rate, oxygen saturation values, 
and hemodynamic   parameters or in sedation or sleep time 
among the three groups. In children undergoing longer surgi-
cal procedures below the umbilicus, a repeat caudal block 
can be done at the end of surgery. If prolonged operative or 
postoperative analgesia is required, a caudal catheter can be 
inserted for the   administration of either repeated bolus doses 
or a   continuous infusion in pediatric patients undergoing 
perineal, lower abdominal or lower extremity surgery.
High caudal block
In children undergoing orchidopexy a higher level of   blockade 
(up to T4) may be necessary to block the peritoneal stimulation 
arising from spermatic cord traction. Using a higher volume or 
placing a catheter to reach a higher   position and delivering the 
drug close to the surgical dermatome are the main ways to block 
a higher segment when a higher level block is necessary.
A high volume aids the spread of the local anesthetic 
in the epidural space and increases the duration of postopera-
tive analgesia. Increasing the volume of 0.25% bupivacaine 
to more than 1 mL/kg blocks the signs of the peritoneal Journal of Pain Research 2010:3 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
115
Pediatric pain management
  stimulation although it can result in motor weakness of the 
lower extremities which becomes significant when epineph-
rine is added to the bupivacaine solution. Wolf and colleagues 
compared the efficacy of 0.125% bupivacaine with that of 
0.25% bupivacaine placed in the caudal space for postopera-
tive analgesia.53 Those children who had caudal blocks with 
0.125% bupivacaine at the completion of surgery analgesia 
was just as effective as that produced by 0.25% bupiva-
caine although with less evidence of motor weakness in the 
postoperative period and thus allowing them to ambulate 
earlier. It is important to note that the local anesthetic must 
be diluted with preservative free normal saline solution. The 
total mg/kg dosage should always be checked to ensure that 
it is within the acceptable safe dose of the drug. In another 
study of healthy children undergoing orchidopexy at our 
institution, a caudal block performed with a higher volume of 
dilute (0.2%) bupivacaine was more effective in blocking the 
peritoneal stimulation during spermatic cord traction than 
the lower volume of the more concentrated (0.25%) solu-
tion. A significant point in this study was that the same total 
dose of local anesthetic was used in all children and there 
was no change in the quality of postoperative analgesia.54 
Another prospective, randomized, observer-blind study of 
children aged 1–5 years-of-age were given a constant dose of 
2.25 mg/kg of ropivacaine solution containing a radiopaque 
dye either as 1.0 mL/kg of 0.225% (low volume/high con-
centration) or 1.5 mL/kg of 0.15% solution (high volume/low 
concentration). The results, confirmed with fluoroscopy, that 
a caudal block with 1 mL/kg ropivacaine spreads to T11 and 
to T6 with 1.5 mL/kg and of that for a total fixed dose, caudal 
analgesia with a larger volume of diluted ropivacaine (0.15%) 
provides better quality and longer duration after discharge 
than a smaller volume of more concentrated ropivacaine 
(0.225%) in children undergoing day-case orchiopexy.55
Continuous epidural anesthesia
The most common sites of epidural catheter insertion are 
(1) caudal (placed via the sacrococcygeal ligament) (2) lumbar 
and (3) in the thoracic area. Epidural catheter placement allows 
repeated injections or the use of continuous infusions to provide 
prolonged blockade. Placing the epidural catheter as close to 
the dermatome affected by the surgical incision allows the local 
anesthetics to be placed close to the segments that are necessary 
to be blocked for adequate pain relief with minimal doses.
Caudal epidural
The caudal space can be entered by the same technique as 
in the single shot caudal technique. Instead of a 23 G needle, 
either a Tuohy or a Crawford epidural needle through the 
  sacrococcygeal membrane can be inserted. The bevel of 
the needle should be pointed posteriorly in order to advance 
the catheter easily. After confirming that there is no blood or 
cerebrospinal fluid on aspiration, the measured length of caudal 
catheter can be threaded through this needle into the desired 
location. The advantage of using continuous caudal block with 
general anesthesia is that it reduces the requirements of intra-
operative inhaled anesthetics and opioids lessening the need 
for postoperative mechanical ventilation especially in neonates 
and ex-premature infants with pulmonary problems. Caudal 
epidural anesthesia via a catheter has been used as the sole 
mode of anesthesia in ex-premature infants having inguinal 
hernia repair without any postoperative problems.56 In a study 
of 20 premature, high-risk infants undergoing abdominal or 
thoracic surgery under combined caudal epidural and general 
anesthesia, epidurography confirmed 17 of the catheters to be 
in the desired location. However, in 2 patients the catheters 
were misplaced within the dura, epidural vessel lumen and 
one was coiled within the epidural space.57
Caudal catheters can be advanced cephalad to a high 
lumbar or thoracic position in infants and children. The cath-
eter should not be forced but smoothly and gently threaded 
into the desired position and the position of the catheter tip 
confirmed radiologically.
A study that looked at the efficacy of using the caudal 
approach to thoracic epidural anesthesia in children showed 
the catheter tip to be within two vertebrae of the target posi-
tion by radiologic confirmation in 17 out of 20 children.58 
The caudal canal has been used successfully to place thoracic 
epidural catheters by using the electrical nerve stimulation 
guidance as well as the electrocardiographic guidance in a 
study of infants.59,60 Reports of infection with caudal catheters 
in children are rare and daily inspection and strict asepsis with 
tape and clean bio-occlusive barrier dressing of the catheter 
site is crucial to avoid infection. In a study of 91children, 
there was an increased incidence of epidural catheter tip 
colonization reported with the caudal route of insertion, and 
the bacteria differed from those cultured from the lumbar 
insertion site. A higher incidence of gram-negative bacteria 
was cultured from the caudal catheter tips than from the 
lumbar epidural catheter tips.61 Tunneling the catheter under 
the skin to a higher position has also been used to minimize 
contamination in some patients who required anesthesia for 
a prolonged period.62 Difficulty in maintaining the catheter 
insertion site free of fecal contamination has led many pedi-
atric anesthesiologists to place the epidural catheters via the 
lumbar and thoracic area instead of the caudal area.Journal of Pain Research 2010:3 submit your manuscript | www.dovepress.com
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Lumbar epidural
Continuous lumbar epidurals can be performed   successfully in 
small children. Epidural blockade to T10 (thoracic   dermatome 
corresponding to the umbilicus) provides analgesia for 
surgery in the lower limb, perineal, urologic and inguinal 
areas. A higher level up to T4-T6 (thoracic dermatome cor-
responding to the nipple line) is necessary for abdominal and 
lower thoracic surgery. Lumbar   epidural anesthesia was used 
intraoperatively and continued for 72 hours for postoperative 
analgesia in 20 neonates undergoing major thoracoabdominal 
surgeries. All neonates except one were extubated when awake 
at the end of the surgery in the operating room and there were 
no complications from the epidural placement.63 Radiological 
imaging using a dye is very useful with this type of anesthesia 
in very small infants to confirm the position of the catheter.64 
A review of epidural anesthesia in 240 neonates showed an 
incidence of one intravascular migration of catheter, one dural 
puncture, and one of convulsions. Intraoperative analgesia was 
effective in all and the majority of these patients had intermit-
tent top-up instead of continuous infusion.65
Thoracic epidural
Placement of thoracic epidural catheters in children should only 
be done by anesthesiologists who are   thoroughly   experienced 
in placing lumbar epidural catheters in children and clearly 
not by beginners. Experience of the manual skills in placing 
lumbar epidural catheters in children must be   demonstrated 
before a thoracic epidural   placement is considered in an infant. 
It is also helpful to observe an   experienced anesthesiologist 
place thoracic epidural catheters for pain control during and 
after extensive thoracoabdominal   surgeries in older children 
and adults before attempting a   thoracic   epidural in a child or an 
infant. The spinous   processes in the thoracic area are longer, 
slant   downward at a sharper angle and the interspaces are 
  narrower. The   introducer needle therefore needs to be angled 
more cephalad to approach the interspace. Continuous tho-
racic epidural infusions placed preoperatively (T3-T8 level) 
have been used in children undergoing pectus repair for 
intra- and postoperative analgesia with excellent results.66 
A thoracic epidural blockade is essential for pain control in 
the   perioperative period after the newer minimally invasive 
repair of the pectus deformity (The Nuss Procedure) where a 
retrosternal metal bar is placed in the chest   thoracoscopically. 
In this procedure although there is no cartilage resection or 
osteotomy, the pain from the bar placement is sufficient to 
warrant a well-established thoracic epidural blockade before 
surgery and has been used successfully in children as young 
as 7 years-of-age.67 In a retrospective review of 220 children 
undergoing pediatric cardiac surgery under general anesthesia 
supplemented with regional anesthesia techniques, Peterson 
and colleagues showed that the use of a thoracic epidural 
catheter was associated with the lowest incidence of adverse 
effects.68 The safety of insertion and maintenance of thoracic 
epidural anesthesia in 63 infants and children was reported to 
be very high with no incidence of dural puncture.69 Lumbar 
and low thoracic catheters can be threaded up to block higher 
thoracic levels if the site of the operation is higher. However, 
a very high block (T1-T4) can also result in bradycardia, 
hypotension and reduced cardiac output by blocking the car-
diac sympathetic outflow from the vasomotor center. Unlike 
adults, epidural catheters are placed in children when they are 
asleep or deeply sedated and therefore, eliciting paresthesia 
is not possible.70 The risk of spinal cord injury is real and 
extreme care should be taken to avoid it during a thoracic 
epidural placement.71 In a prospective, randomized study 
in 64 children 0–6 years-of-age undergoing major surgery, 
the ultrasound guidance for epidural catheter placement 
was compared to the standard or loss-of-resistance (LOR) 
technique for placing epidural catheters at lumbar or thoracic 
cord levels. Using a 5–10 MHz linear ultrasound probe, the 
authors identified the neuraxial structures, measured the skin-
epidural depth and epidural space, visualized the advancing 
epidural catheter, and verified the catheter position as well as 
the spread of local anesthetic. They found that the epidural 
placement involved bone contacts in only 17% of children in 
the ultrasound group compared to the 71% of children in the 
LOR group (P , 0.0001). Epidurals were also placed more 
swiftly in the ultrasound group. The authors concluded that 
ultrasonography is a useful aid to verify epidural placement of 
local anesthetic agents and epidural catheters in children with 
advantages that include a reduction in bone contacts, faster 
epidural placement, direct visualization of neuraxial structures 
and the spread of local anesthetic inside the epidural space. 
Although the ultrasound guidance technique is clearly supe-
rior, it requires additional training and good manual skills, 
it should only be used once experience in ultrasound-guided 
techniques of regional anesthesia has been acquired.72
Patient controlled epidural anesthesia
Older children and teenagers who can understand how to use the 
PCA devices can be given autonomy over their pain control by 
allowing them to self administer boluses of local anesthetic if 
needed for pain relief. This technique, which has become popu-
lar in adults, is known as patient controlled   epidural anesthesia 
(PCEA) can be very   useful in   managing postoperative pain in 
older children and   adolescents. In   addition to self-administered Journal of Pain Research 2010:3 submit your manuscript | www.dovepress.com
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boluses, a continuous   background infusion is always used in 
PCEA. PCEA is usually used after extensive abdominal, thoracic 
surgeries (eg, pectus repair), extensive lower limb and spinal 
surgeries. Orders for the PCEA should have, in addition to the 
drug concentration (local anesthetic and an opioid,   usually 
fentanyl), volume and basal infusion rate, bolus dose, lockout 
period and the number of hourly boluses. Since the time needed 
for a bolus dose to produce a change is longer with epidural 
compared with IV drug administration the lockout interval is 
longer, usually 15 minutes compared to 5–8 minutes.
In an earlier study, the efficacy of this modality of pain 
treatment was evaluated in 128 children, and satisfactory 
analgesia without serious toxicity or side effects was reported 
in children as young as 5 years of age.73 In another study of 
48 children both continuous epidural anesthesia (CEA) and 
PCEA with 0.2% ropivacaine provided adequate pain relief in 
the first 48 hours after orthopedic surgery. However adequate 
analgesia was obtained with 50% less volume infused with 
PCEA as compared with CEA.74 This is a potential advantage 
if the technique is going to be used in a younger patient for 
a longer period of time. In a recent study, parent-assisted or 
nurse-assisted epidural analgesia was also found to be safe in 
children undergoing surgery who are physically or cognitively 
unable, or unwilling to self-activate a demand dose.75
The use of a percutaneously inserted, subcutaneously tun-
neled epidural catheter for prolonged analgesia in pediatric 
patients has been found to be safe and an extremely effective 
method of providing analgesia in children suffering pain from 
end stage malignancies.76
Bupivacaine toxicity and convulsions have occurred in 
children receiving large doses of bupivacaine via continu-
ous caudal or epidural infusions. When planning to initiate 
epidural bupivacaine, it has been suggested that after a load-
ing dose of 2–2.5 mg/kg, infusion rates should not exceed 
a rate of 0.4–0.5 mg/kg/hour for older infants, toddlers, 
and children, or 0.2–0.25 mg/kg per hour for neonates.78 
Dilute bupivacaine solution (0.1%) combined with fentanyl 
1–2 µg/mL is commonly used for effective pain control. If 
the catheter tip is positioned at lumbar or caudal levels for 
upper abdominal surgery, hydrophilic opioids (eg, morphine 
or hydromorphone) should be used. Irrespective of the com-
bination of local anesthetics and narcotics, it is crucial to plan 
for appropriate postoperative monitoring in all the patients 
after initiating the epidural infusion.
Local anesthetics
Test dosing is not usually practical or sensitive since most 
blocks are performed with the children anesthetized or 
heavily sedated. Detection of accidental intravascular   
(or intraosseous) injection is extremely difficult. Local anes-
thetic toxicity is extremely rare in infants and children when 
the drug dose guidelines are followed and when the procedure 
is performed by experienced anesthesiologists. However, sei-
zures, dysrhythmias, and cardiovascular collapse have all been 
reported. Since large volumes are used in caudal and epidural 
infusions; and because the elimination may be delayed in 
neonates because of decreased protein binding, there is always 
a higher risk for toxicity in the younger age group.
Bupivacaine
Bupivacaine has the worst toxicity profile among the amide 
local anesthetics and the ratio of the cardiotoxic to the con-
vulsant dose for this drug is lower than that for most other 
local anesthetics. Despite this well known fact, bupivacaine 
still remains the most commonly used drug for regional 
anesthesia in infants and children. The maximum recom-
mended single bolus dose of bupivacaine is 2.5–3.0 mg/kg. 
The maximum recommended infusion rate for bupivacaine 
is 0.4–0.5 mg/kg/hour (10–2 mg/kg/day) in older infants 
and children, and 0.2–0.25 mg/kg/hour (5 to 6 mg/kg/day) 
in neonates. Most of the reports of convulsions associated 
with bupivacaine infusions have occurred during infusions 
in excess of the recommended limits. Cardiac toxicity from 
bupivacaine, including myocardial depression and dysrhyth-
mias, can be quite refractory to treatment. The toxic plasma 
concentration of bupivacaine is 4 µg/mL.78
The main binding protein for bupivacaine is α1-acid 
glycoprotein. In infants, the presence of free versus bound 
bupivacaine in the plasma is of critical importance in exam-
ining the risk of bupivacaine toxicity. In adults, bupivacaine 
is approximately 95% bound to plasma proteins; and only 
5% of the measured bupivacaine concentration is available 
to produce toxic reactions in the myocardium and central 
nervous system. Levels of α1-acid glycoprotein, and thus 
bupivacaine free fractions, in older infants and children are 
comparable to the values seen in adults. However, α1-acid 
glycoprotein levels in neonates and infants younger than 
6 months can be less than 50% of those seen in children 
and adults, and free bupivacaine concentrations can exceed 
20%. Levels of α1-acid glycoprotein can be particularly low 
in premature infants, but increase during early infancy and 
approach adult values by 6 months of age.79
Ropivacaine and levobupivacaine
Ropivacaine and levobupivacaine are enantiomerically 
pure compounds rather than racemic mixtures of two Journal of Pain Research 2010:3 submit your manuscript | www.dovepress.com
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  stereoisomers. They both have anesthetic potency   equivalent 
to bupivacaine while having a lower toxicity and less 
unwanted motor blockade.80 Since they display the same 
pharmacokinetic profile as racemic bupivacaine with less 
cardiac toxicity, continuous infusion of these local anesthet-
ics offers the safest therapeutic index, especially in infants.
Ropivacaine
Ropivacaine produces less motor block than equivalent con-
centrations of bupivacaine. In addition, ropivacaine under-
goes slower absorption from the caudal epidural space in 
children compared to bupivacaine, which is possibly due to 
its intrinsic vasoconstrictor properties. It has an anesthetic 
potency equivalent to bupivacaine and a toxic threshold much 
higher than that of bupivacaine in animal models. The fatal 
dose of ropivacaine in sheep has been shown to be almost 
twice that of bupivacaine (7.3 versus 3.7 mg/kg). In human 
volunteers, larger doses of ropivacaine than bupivacaine are 
tolerated before the development of toxicity symptoms.81
Controversies still abound regarding the supposed lower 
potency of ropivacaine when comparing ropivacaine with 
bupivacaine in adult studies. In order to obtain an equian-
algesic effect, a higher concentration seems to be required 
thus partially reducing the advantage of lower toxicity and 
leading to a similar therapeutic ratio. However, this data is 
different from the pediatric experience where 0.2% ropiva-
caine has been demonstrated to have an equianalgesic effect 
with 0.25% bupivacaine making the safe therapeutic window 
wider.82
Ropivacaine concentrations used for caudal and   epidural 
anesthesia in children typically range from 0.2%–0.25% in 
a volume of 1 mL/kg. Loading doses of 0.2%   ropivacaine 
for epidural anesthesia in infants and children range from 
0.5–0.85 mL/kg. Caudal or epidural anesthesia with com-
parable concentrations and volumes of ropivacaine or bupi-
vacaine produces equivalent analgesia.83
Levobupivacaine
Levobupivacaine, the levorotatory enantiomer of racemic 
bupivacaine has been studied in animal models and has 
been shown to have a lower toxic potential when compared 
with dexbupivacaine. The toxicity of levobupivacaine 
may be intermediate to those of racemic bupivacaine and 
ropivacaine. Studies of the effects of intravenous infusion of 
levobupivacaine and racemic bupivacaine in sheep found that 
convulsions occurred sooner, lasted longer, and required a 
lower dose after infusion of bupivacaine racemate compared 
with levobupivacaine.84
In adults, the peak plasma concentration of   levobupivacaine 
is approximately 20%–25% greater than that of bupivacaine 
racemate after either epidural or intravenous administration 
of identical doses. Despite higher plasma concentrations of 
levobupivacaine, the plasma concentration of free (unbound) 
levobupivacaine is lower than that of bupivacaine racemate 
because of greater protein binding of the levorotatory 
enantiomer.
Adjunctive agents
Balancing the efficacy of the anesthetic block with the safety 
of the patient still remains one of the major   challenges 
in   pediatric regional anesthesia. Single injection blocks 
  therefore will not be very popular if a longer duration of 
analgesia is necessary. One way of increasing the   duration 
and efficacy of the block is to use concentrated local anes-
thetic solutions in larger volumes, which, can result in 
unwanted motor blockade. To avoid these problems, various 
additives have been used in order to improve the quality of 
caudal blocks without increasing the total dose of the local 
anesthetic drugs.85 It is a well known fact that additives can 
significantly extend the duration of analgesia. However, what 
is not yet clear is if this results in improved patient outcome, 
or outweighs persistent concerns regarding the potential for 
neurotoxicity of some of the additives.85,86
epinephrine
The effect of adding epinephrine is less pronounced with 
bupivacaine than it is with more hydrophilic drugs such 
as lidocaine. It acts by reducing the systemic uptake of the 
local anesthetic drugs and through its alpha-2 adrenergic 
stimulating properties, enhances the duration and quality of 
both peripheral and neuraxial blocks. Most commercially 
premixed epinephrine-containing local anesthetic solutions 
have a lower pH than plain solutions and this lower pH may 
delay the uptake of the drug across neural membranes.87
Sodium bicarbonate
It has been demonstrated in previous studies that the   elevation 
of the pH of local anesthetics results in a more rapid onset of 
action and enhanced quality and duration of the anesthetic 
block.88 The addition of 0.1 mL of a standard 8.4% solu-
tion of sodium bicarbonate to a 20 mL solution of 0.25% 
  bupivacaine will raise the pH of the local anesthetic from 
5.49 to 7.04. This simple approach is particularly useful 
when commercial epinephrine-containing bupivacaine with 
a low pH is used, or to enhance the effect of a very dilute 
solution of bupivacaine.Journal of Pain Research 2010:3 submit your manuscript | www.dovepress.com
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Neuraxial opioids
Administration of opioids neuraxially results in excellent 
and longer lasting analgesia. When delivered at the epidural 
or spinal site, the opioids bypass the blood brain barrier and 
require significantly less (1/10–1/100th) dose to be effective. 
However, whether the opioid is administered via the caudal, 
epidural, or spinal routes, delayed respiratory depression is 
a potential problem especially in young infants; and when 
there is the concomitant administration of systemic opioids. 
Hydrophilic opioids (eg, morphine or hydromorphone) can 
be administered through lumbar or caudal catheters. With 
these opioids, a wider range of dermatomes can be covered 
after caudal or lumbar catheter placement and only small 
increases in dose are required for a surgical site remote from 
the catheter tip. This same characteristic, unfortunately, also 
appears to increase the risk for side effects including respira-
tory depression as a result of the rostral spread of morphine in 
the cerebrospinal fluid to the central respiratory center in the 
brainstem. Hydromorphone may also offer some advantages 
because there is less rostral spread when administered by the 
epidural route and slightly less pruritus than with morphine; 
although it provides more rostral spread than with fentanyl. 
Lumbar administration spreads sufficiently to provide thoracic 
analgesia. It should be noted that the potency of hydromor-
phone relative to morphine in the epidural space is less than 
when it is administered systemically (2–3:1 epidural versus 
5:1 systemic).1 Other side effects that can be distressing 
include vomiting, urinary retention, postoperative ileus, and 
pruritus. Thus neuraxial administration of opioids requires 
specific routines and protocols for their safe use in children. In 
children following open heart surgery, Rosen and colleagues 
demonstrated that administering caudal epidural morphine 
was an effective mode of treatment of postoperative pain.89
Alpha-2-agonists
Clonidine
Clonidine acts in the brain and spinal cord by stimulating 
alpha-2 inhibitory neurons in the vasomotor center, creating a 
reduction in the sympathetic outflow to the tissues. The addi-
tion of the alpha-2 agonist clonidine to local anesthetic solu-
tions has been shown to enhance the duration and quality of 
central and peripheral nerve blocks. When administered into 
the spinal or epidural space, clonidine acts presynaptically at 
C-fibers and postsyaptically on dorsal horn neurons through 
a G-1 coupled K+ channel and leads to spinal   analgesia and 
decreased central sensitization.90
Clinically, the addition of clonidine (1–2 µg/kg) to a   single 
injection bolus of a local anesthetic has been   consistently 
shown to substantially prolong the duration of the caudal 
blockade. The addition of clonidine in doses of approximately 
0.1 µg/kg/hour significantly enhances the analgesic quality 
of continuous epidural infusions. The main advantage of 
clonidine (compared to the opioids) is the negligible risk 
of respiratory depression. In addition the higher incidence of 
mild-to-moderate sedation with clonidine is actually advan-
tageous following major surgery in hospitalized children 
although not desirable in ambulatory patients.
Dexmedetomidine
Dexmedetomidine hydrochloride (Precedex®), a compound 
derived from imidazole, is a potent and highly selective 
(8 times higher than clonidine) alpha2-adrenoreceptor agonist. 
The addition of clonidine or dexmedetomidine to bupivacaine 
prolongs caudal analgesia in children.91 Dexmedetomidine is 
known to have sedative, hypnotic and analgesic properties. It 
diminishes the need for other anesthetics and sympatholyt-
ics, and it reduces the release of catecholamine. The site of 
action for the sedative action of this drug is considered to be 
the locus coeruleus. Caudally administered dexmedetomidine 
(1 µg/kg), combined with bupivacaine was studied in children 
ages 1–6 years-of-age undergoing unilateral hernia repair and 
the results showed an extended duration of postoperative pain 
relief.92 Caudal dexmedetomidine seems to be a promising 
adjunct to provide excellent analgesia without side effects over 
a 24hour period. Dexmedetomidine has the added   advantage 
of keeping the patients calm for a prolonged time.
S-ketamine
The analgesic effect of caudal administered ketamine is 
believed to result from the interaction with NMDA or 
opioid receptors at the spinal level. As with clonidine, the 
main advantage of using epidural ketamine is the lack of 
respiratory depression. Using a bolus dose of up to 1 mg/kg 
of caudal or epidural preservative free ketamine the risk 
of psychological side effects appears to be low. Thirty 
children (ASA I-II, 1 month–9 years) scheduled for minor 
inguinal or penile surgery, were randomly assigned in a 
prospective, double-blind fashion to receive single shot 
caudal blockade by either bupivacaine 0.125% 1 mL/kg or 
a mixture of   bupivacaine 0.125% 1 mL/kg and preservative 
free s-  ketamine 0.5 mg/kg. The addition of 0.5 mg/kg of 
preservative free s-ketamine to caudal bupivacaine (0.125% 
at 1 mL/kg) provided a significant prolongation of analgesia 
without producing negative side-effects.93
Another study looked at the addition of 0.5 mg/kg 
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analgesia in lower abdominal and urological surgery and 
found that the addition of s(+)-ketamine was significantly 
more   effective in providing postoperative analgesia than 
levobupivacaine (0.15%) with 0.5 mg/kg s(+)-ketamine or 
0.2%   levobupivacaine alone.94
Neostigmine
Analgesia and the side-effects associated with caudal 
  neostigmine, co-administered with bupivacaine for pediatric 
surgery has been studied and have concluded that caudal 
  neostigmine, when given in a dose of 20–50 µg/kg,   provides 
dose dependent analgesia. However, doses exceeding 
30 µg/kg are associated with a higher incidence of nausea and 
vomiting.95 A single caudal injection of neostigmine 2 µg/kg 
combined with 0.2% ropivacaine offers an advantage over 
ropivacaine alone for postoperative pain relief in preschool 
children undergoing genitourinary surgery.96
Tramadol
The addition of tramadol to bupivacaine for caudal   epidural 
block in children significantly prolongs the duration of 
postoperative analgesia. Tramadol, a synthetic analogue 
of codeine, is a racemic mixture of two enantiomers; (+) 
tramadol and (–) tramadol and is a unique analgesic with 
mu-1 agonist activity. The (+) enantiomer has a moderate 
affinity for the opioid µ-receptor and also inhibits serotonin 
uptake, while the (–)-enantiomer is a potent norepineph-
rine inhibitor. These complementary properties result in 
an opioid with an analgesic potency approximately equal 
to that of meperidine, but without any respiratory depres-
sant effect.
Caudal tramadol 2 mg/kg, combined with bupiva-
caine (0.25% at 0.75 mL/kg) provided longer duration of 
  postoperative analgesia and reduced the requirement for 
rescue analgesia compared with tramadol 1 mg/kg or 
1.5 mg/kg in 80 children (2–8 years-of-age) undergoing 
inguinal herniotomy.97 Another study of 75 children, aged 
between 3 and 9 years showed that caudally administered 
0.25% bupivacaine (at 0.5 mL/kg) plus ketamine or 0.25% 
bupivacaine plus tramadol (at 1 mg/kg) provided significantly 
longer analgesia without an increase in the adverse effects 
when compared to bupivacaine alone.98
Midazolam
A prospective, randomized, double-blind study aimed to 
determine whether caudal midazolam combined with ropi-
vacaine affects anesthetic requirements, recovery profiles, 
and postoperative analgesia, compared with ropivacaine 
alone, was recently undertaken with 60 boys aged between 
2–5 years. Caudal midazolam (50 µg/kg) added to 2% 
  ropivacaine (at 1 mL/kg) with epinephrine 1:200,000 was 
found to provide improved postoperative analgesia when 
compared with 2% ropivacaine with epinephrine 1:200,000 
alone in these young children undergoing hernia repair in a 
pediatric ambulatory setting.99
Summary
Effective postoperative analgesia in infants and young 
  children continues to evolve with innovative methods of 
therapy using newer drugs or older drugs introduced via 
novel routes. Age appropriate pain assessment tools con-
tinue to be critically evaluated, validated and improved as 
one of the most critical components of pain management. 
A multimodal approach to preventing and treating pain is 
usually used to minimize the side effects of individual drugs 
or techniques.100 Regional analgesia must be considered 
unless contraindicated. Bupivacaine, a long acting well-
studied local anesthetic is most commonly used in children. 
Both ropivacaine and levobupivacaine may find their use, 
in neonates, in patients with impaired hepatic function 
where prolonged infusions are needed and for anesthetic 
techniques requiring a large mass of a local anesthetic drug. 
Ultrasonography guidance blocks will probably become 
the reference technique for local anesthetic injections and 
regional anesthesia catheter placement; which will benefit 
from new training in this field.101,102
Finally, a well-organized pediatric pain service which 
includes well trained pediatric anesthesiologists who can 
teach the trainees daily and act as pain consultants to the 
other departments of the hospital together with a group of 
equally committed and specially trained nursing staff is 
essential for the successful management of acute pain in 
infants and children.
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